DSM-5 Changes on the Horizon: Substance Use Disorders

REFERENCES

• Airavaara, M., Fanous, S., Hope, B. T., Pickens, C. L., Shaham, Y., & Theberge, F. (2011). Neurobiology of the incubation of drug craving. Trends in Neurosciences, 34(8), 411.
   Google Scholar
• Alarcon, R. (2009). Inside the DSM-V process: Issues, debates, and reflections. Psychiatric Times, 26(7). Retrieved from http://www.psychiatrictimes.com/display/article/10168/1426119
   Google Scholar
• American Psychiatric Association. (1952). Diagnostic and statistical manual of mental disorders. Washington, DC: Author.
   Google Scholar
• American Psychiatric Association. (1968). Diagnostic and statistical manual of mental disorders (2nd ed.). Washington, DC: Author.
   Google Scholar
• American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders (3rd ed.). Washington, DC: Author.
   Google Scholar
• American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed., rev.). Washington, DC: Author.
   Google Scholar
• American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
   Google Scholar
• American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
   Google Scholar
• American Society of Addiction Medicine. (2011). Public policy statement: Definition of addiction. Retrieved from http://www.asam.org/Definitionof Addiction-LongVersion.html
   Google Scholar
• Angell, M. (2011). The epidemic of mental illness [book review]. Retrieved from http: //www.nybooks.com/articles/archives/2011/jul/14/illusions-of-psychiatry/?pagination=false
   Google Scholar
• Banzato, C. E. M. (2004). Classification in psychiatry: The move towards ICD-11 and DSM-V. Current Opinions in Psychiatry, 17, 497–501.
   Google Scholar
• Bartolome, J. M., & Sartorius, N. (1994). Classification of mental diseases. From Bertillon to CID-10: A century of international collaboration. Actas Luso-Espanolas de Neurologia, Psiquiatria y Ciencias Afines. Retrieved from http:www.ncbi.nlm.nih.gov /pubmed/8512023
   Google Scholar
• Bekelman, J. E., Li, Y., & Gross, C. P. (2003). Scope and impact of financial conflicts of interest in biomedical research: A systematic review. Journal of the American Medical Association, 289(4), 454–465.
   PubMed Web of Science ®Google Scholar
• Berkrot, B. (2010). US prescription drug sales hit $300 billion. Retrieved from http: //www.reuters.com/article/idUSN3122364020100401
   Google Scholar
• Bhandari, M., Busse, J. W., & Jackowski, D. (2004). Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trails. Canadian Medical Association Journal, 170(4), 477–480.
   PubMed Web of Science ®Google Scholar
• Blashfield, R., & Flannigan, E. (2012). Increasing clinical utility by aligning the DSM and ICD with clinicians’ conceptualizations. Professional Psychology, Research and Practice 41.6(2010), 474+. Health Reference Center Academic. doi: http: //dx.doi.org/10.1037/a0021603
   Google Scholar
• Compton, W. M., Thomas, Y., Stinson, F., & Grant, B. (2007). Prevalence, correlates, disability and co-morbidity of DSM-IV drug abuse and dependence in the United States. Archives of General Psychiatry, 64(5), 566–576.
   PubMed Web of Science ®Google Scholar
• Djulbegovic, B., Lacevic, M., Cantor, A., Fields, K., Bennett, C., Adams, J., & Lyman, G. (2000). The uncertainty principle and industry-sponsored research. Lancet, 356(9230), 635–638.
   Google Scholar
• Fareed, A., Vayalapalli, S., Casarella, J., & Drexler, K. (2012). Treatment outcome for flexible dosing buprenorphine maintenance treatment. The American Journal of Drug and Alcohol Abuse, 38(2), 155–160.
   PubMed Web of Science ®Google Scholar
• Fuller, B. E., McCarty, D., Rieckmann, T., & Saedi, G. A. (2010). Adoption of practice guidelines and assessment tools in substance abuse treatment. Substance Abuse Treatment, Prevention, and Policy, 5, 4.
   Google Scholar
• Gugger, J. J., & Cassagnol, M. (2008). Low-dose quetiapine is not a benign sedative-hypnotic agent. American Journal on Addictions, 17(5), 454–455.
   PubMed Web of Science ®Google Scholar
• Haney, M., & Spealman, R. (2008). Controversies in translational research: Drug self-administration. Psychopharmacology, 199(3), 403
   PubMed Web of Science ®Google Scholar
• Heit, H. (2011). Definitions: Addiction, dependence, tolerance. Addiction, 106, 873–874. Retrieved from http: //www.QuantiaMD.com/home/heit
   Google Scholar
• Heyman, G. (2009). Addiction, a disorder of choice. Cambridge, MA: Harvard University Press.
   Google Scholar
• Hughes, J., Gabbay, M., Funnell, E., & Dowrick, C. (2012). Exploratory review of placebo characteristics reported in randomized placebo controlled antidepressant drug trials. Pharmacopsychiatry, 45(1), 20–27.
   Google Scholar
• Hyman, S. E. (2003). Diagnosing disorders. Scientific American, 289, 96–103. Retrieved from http: //www.scientificamerican.com/article.cfm?id= diagnosing-disorders
   Google Scholar
• Jablensky, A., & Kendell R. E. (2002). Criteria for assessing a classification in psychiatry. In M. Maj (Ed.), Psychiatric diagnosis and classification (pp. 1–24). West Sussex, England: John Wiley and Sons.
   Google Scholar
• Jellineck, E. M. (1960). The disease concept of alcoholism. New Haven, CT: Hillhouse.
   Google Scholar
• Kelly, T., Daley, D., & Douaihy, A. (2012). Treatment of substance abusing patients with comorbid psychiatric disorders. Addictive Behaviors, 37(1), 11–24.
   PubMed Web of Science ®Google Scholar
• Kendell, R. E. (2002). Five criteria for an improved taxonomy of mental. In J. E. Helzer & J. Hudziak (Eds.), Defining psychopathology in the 21st century: DSM-V and beyond (pp. 3–18). Washington, DC: American Psychiatric Publishing.
   Google Scholar
• Kukich, D. S., & Varrin, R. D. (1985). Guidelines for industry-sponsored research at universities. Science, 227, 385.
   Google Scholar
• Leshner, A. (1997). Addiction is a brain disease and it matters. Science, 278 (5335), 45–47.
   PubMed Web of Science ®Google Scholar
• Lubin, G., & Jenkins, C. (2011). The 15 highest grossing prescription drugs in America. Business Insider. Retrieved from http://www.businessinsider.com/ highest-gross-prescription-drugs-2011-4#15-oxycontin-1#ixzz1bWsZKjor
   Google Scholar
• Luoma, J., Twohig, M., Waltz, T., Hayes, S. C., Roget, N., Padilla, M., & Fisher, G. (2007). An investigation of stigma in individuals receiving treatment for substance abuse. Addictive Behaviors, 32(7), 1331–1346.
   PubMed Web of Science ®Google Scholar
• Meyer, R. (2011). Addiction and dependence in DSM-V. Addiction, 106, 866–867.
   Google Scholar
• Millon, T. (1991). Classification in psychopathology: Rationale, alternatives, and standards. Journal of Abnormal Psychology, 100, 245–261.
   PubMed Web of Science ®Google Scholar
• Mishra, S., Bhatnagar, S., Goyal, G., Singh, S., & Upadhya, S. (2012). A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: A prospective randomized double-blind placebo-controlled study. American Journal of Hospice & Palliative Medicine, 29(3), 177–182.
   PubMed Web of Science ®Google Scholar
• Neuman, J., Korenstein, D., Ross, J., & Keyhani, S. (2011). Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: Cross sectional study. BMJ (Clinical Research Ed.), 343, d7063.
   Google Scholar
• O'Brien, C. (2011). Addiction and dependence in DSM-V. Addiction, 106, 866–867.
   PubMed Web of Science ®Google Scholar
• O'Brien, C. P., Volkow, N., & Li, T-K. (2006). What's in a word? Addiction versus dependence in DSM-V. American Journal of Psychiatry, 163, 764–765.
   PubMed Web of Science ®Google Scholar
• Petry, N., Stinson, F., & Grant, B. (2005). Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. The Journal of Clinical Psychiatry, 66(5), 564–574.
   PubMed Web of Science ®Google Scholar
• Pittenger, C., & Desan, P. (2007). Gabapentin abuse and delirium tremens upon gabapentin withdrawal. The Journal of Clinical Psychiatry, 68(3), 483–484.
   PubMed Web of Science ®Google Scholar
• Potenza, M. (2008). Review. The neurobiology of pathological gambling and drug addiction: An overview and new findings. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 363(1507), 3181–3189.
   PubMed Web of Science ®Google Scholar
• Recoppa, L. (2010). Less abuse potential with XR formulation of quetiapine? The American Journal on Addictions, 20,178.
   Google Scholar
• Ross, J. S., Gross, C. P., & Krumholz, H. M. (2012). Promoting transparency in pharmaceutical industry-sponsored research. American Journal of Public Health, 102(1), 72–80.
   PubMed Web of Science ®Google Scholar
• Safer, T. (2002). Design and reporting modifications in industry-sponsored comparative psychopharmacology trials. The Journal of Nervous and Mental Diseases, 190(9), 583–592.
   Google Scholar
• Saha, T., Compton, W., Chou, S., Smith, S., Ruan, W., Huang, B., & Grant, B. (2012). Analyses related to the development of DSM-V criteria for substance use related disorders: 1. Toward amphetamine, cocaine and prescription drug use disorder continua using Item Response Theory. Drug & Alcohol Dependence, 122(1–2), 38–42.
   Google Scholar
• Sinyor, M., Schaffer, A., Smart, K. A., Levitt, A. J., Lanctot, K. L., & Grysman, N. H. (2012). Sponsorship, antidepressant dose, and outcome in major depressive disorder: Meta-analysis of randomized controlled trials. The Journal of Clinical Psychiatry, 273(2), 277–287.
   Google Scholar
• Slutske, W., Blaszczynski, A., & Martin, N. (2009). Sex differences in the rates of recovery, treatment-seeking, and natural recovery in pathological gambling: Results from an Australian community-based twin survey. Twin Research and Human Genetics: The Official Journal of the International Society for Twin Studies, 12(5), 425–432.
   PubMed Web of Science ®Google Scholar
• Stahl, S. (2011). Is the DSM-V Necessary? Retrieved from www.http: // go.neiglobal.com/blog/tabid/83/EntryId/17/Is-the-DSM-V-Necessary.aspx
   Google Scholar
• Szalavitz, M. (2011). Addiction science is all brain, no heart. Retrieved from http: //www.thefix.com/content/earth-experts-addiction-more-brain- disorder8010?page=all
   Google Scholar
• Weiss, M. (2011). Drug addiction in the DSM-V … Considerations for the future. Biology Magazine. Retrieved from http: //en.paperblog.com/drug-addicition-in-the-dsm-vconsiderations-for-the-future-19552
   Google Scholar
• Zack, M., & Poulos, C. (2009). Parallel roles for dopamine in pathological gambling and psychostimulant addiction. Current Drug Abuse Reviews, 2(1), 11–25.
   Google Scholar
• Zimmerman, M., & Spitzer, R. L. (2008). Psychiatric classification. In B. J. Sadock & V. A. Sadock (Eds.). Kaplan's and Sadock's comprehensive textbook of psychiatry. Philadelphia, PA: Lippincott Williams and Wilkins.
   Google Scholar